181 related articles for article (PubMed ID: 23437153)
1. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.
Chen F; Sarabipour S; Hristova K
PLoS One; 2013; 8(2):e56521. PubMed ID: 23437153
[TBL] [Abstract][Full Text] [Related]
2. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
3. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
4. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
[No Abstract] [Full Text] [Related]
5. Crouzon syndrome with acanthosis nigricans: a case-based update.
Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
[TBL] [Abstract][Full Text] [Related]
6. [Acanthosis nigricans in children and Crouzon syndrome].
Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
Mir A; Wu T; Orlow SJ
JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
[TBL] [Abstract][Full Text] [Related]
9. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
10. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
[TBL] [Abstract][Full Text] [Related]
11. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
[TBL] [Abstract][Full Text] [Related]
12. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
[TBL] [Abstract][Full Text] [Related]
13. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
[TBL] [Abstract][Full Text] [Related]
14. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders.
Merzlyakov M; You M; Li E; Hristova K
J Mol Biol; 2006 Apr; 358(1):1-7. PubMed ID: 16500676
[TBL] [Abstract][Full Text] [Related]
16. Crouzonodermoskeletal Syndrome with Hypoplasia of Corpus Callosum and Inferior Vermis.
Gürbüz F; Ceylaner S; Topaloğlu AK; Yüksel B
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):373-4. PubMed ID: 27181494
[No Abstract] [Full Text] [Related]
17. The pathogenic A391E mutation in FGFR3 induces a structural change in the transmembrane domain dimer.
Mudumbi KC; Julius A; Herrmann J; Li E
J Membr Biol; 2013 Jun; 246(6):487-93. PubMed ID: 23727984
[TBL] [Abstract][Full Text] [Related]
18. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
Nagase T; Nagase M; Hirose S; Ohmori K
Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
[TBL] [Abstract][Full Text] [Related]
19. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans?
Sharda S; Panigrahi I; Gupta K; Singhi S; Kumar R
Pediatr Dermatol; 2010; 27(1):43-7. PubMed ID: 20199409
[TBL] [Abstract][Full Text] [Related]
20. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]